Novanta Inc (NOVT)vsVuzix Corp Cmn Stk (VUZI)
NOVT
Novanta Inc
$137.77
-2.72%
TECHNOLOGY · Cap: $5.11B
VUZI
Vuzix Corp Cmn Stk
$2.14
-4.89%
TECHNOLOGY · Cap: $187.94M
Smart Verdict
WallStSmart Research — data-driven comparison
Novanta Inc generates 16399% more annual revenue ($1.00B vs $6.09M). NOVT leads profitability with a 5.3% profit margin vs 0.0%. NOVT earns a higher WallStSmart Score of 44/100 (D).
NOVT
Hold44
out of 100
Grade: D
VUZI
Avoid16
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-35.1%
Fair Value
$105.01
Current Price
$137.77
$32.76 premium
Margin of Safety
+40.2%
Fair Value
$4.13
Current Price
$2.14
$1.99 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Conservative balance sheet, low leverage
Conservative balance sheet, low leverage
Areas to Watch
Expensive relative to growth rate
ROE of 5.2% — below average capital efficiency
5.3% margin — thin
Weak financial health signals
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
ROE of -90.3% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : NOVT
The strongest argument for NOVT centers on Debt/Equity. Revenue growth of 10.4% demonstrates continued momentum.
Bull Case : VUZI
The strongest argument for VUZI centers on Debt/Equity.
Bear Case : NOVT
The primary concerns for NOVT are PEG Ratio, Return on Equity, Profit Margin. A P/E of 102.5x leaves little room for execution misses.
Bear Case : VUZI
The primary concerns for VUZI are EPS Growth, Market Cap, Profit Margin.
Key Dynamics to Monitor
VUZI carries more volatility with a beta of 1.75 — expect wider price swings.
NOVT is growing revenue faster at 10.4% — sustainability is the question.
NOVT generates stronger free cash flow (46M), providing more financial flexibility.
Monitor SCIENTIFIC & TECHNICAL INSTRUMENTS industry trends, competitive dynamics, and regulatory changes.
Bottom Line
NOVT scores higher overall (44/100 vs 16/100) and 10.4% revenue growth. VUZI offers better value entry with a 40.2% margin of safety. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Novanta Inc
TECHNOLOGY · SCIENTIFIC & TECHNICAL INSTRUMENTS · USA
Novanta Inc. designs, manufactures, markets and sells precision motion, vision and photonics components and subsystems to original equipment manufacturers in the medical and industrial markets worldwide. The company is headquartered in Bedford, Massachusetts.
Vuzix Corp Cmn Stk
TECHNOLOGY · CONSUMER ELECTRONICS · USA
Vuzix Corporation designs, manufactures, markets and sells augmented reality (AR) computing and display devices for consumer and business markets in North America, Asia-Pacific, Europe, and internationally. The company is headquartered in West Henrietta, New York.
Compare with Other SCIENTIFIC & TECHNICAL INSTRUMENTS Stocks
Want to dig deeper into these stocks?